Optimisation of insulin treatment of type 2 diabetes mellitus by Telecare assistance for self monitoring of blood glucose (SMBG).
Latest Information Update: 01 Jun 2011
At a glance
- Drugs Insulin glargine (Primary) ; Insulin glulisine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms ELEONOR
- Sponsors Sanofi
- 05 Jun 2009 Quality-of-life and treatment satisfaction results presented at ADA 2009.
- 12 May 2009 Actual patient number (352) added as reported by ClinicalTrials.gov.
- 11 Sep 2008 Interim results published in the proceedings of the 44th Annual Meeting of the European Association for the Study of Diabetes.